160 related articles for article (PubMed ID: 2981616)
21. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy.
Cronin CM; Sallan SE; Gelber R; Lucas VS; Laszlo J
J Clin Pharmacol; 1981; 21(S1):43S-50S. PubMed ID: 7028793
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
Heim ME; Queisser W
Onkologie; 1982 Apr; 5(2):94-6. PubMed ID: 7048169
[TBL] [Abstract][Full Text] [Related]
23. Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis.
Stambaugh JE; McAdams J; Vreeland F
J Clin Pharmacol; 1984; 24(11-12):480-5. PubMed ID: 6392353
[TBL] [Abstract][Full Text] [Related]
24. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration.
Laszlo J; Lucas VS; Hanson DC; Cronin CM; Sallan SE
J Clin Pharmacol; 1981; 21(S1):51S-56S. PubMed ID: 7298875
[TBL] [Abstract][Full Text] [Related]
25. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
26. Nabilone: a potent antiemetic cannabinol with minimal euphoria.
Herman TS; Jones SE; Dean J; Leigh S; Dorr R; Moon TE; Salmon SE
Biomedicine; 1977 Dec; 27(9-10):331-4. PubMed ID: 606307
[TBL] [Abstract][Full Text] [Related]
27. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
28. Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
Schwartz RH; Beveridge RA
J Addict Dis; 1994; 13(1):53-65. PubMed ID: 7503819
[TBL] [Abstract][Full Text] [Related]
29. [Levonantradol in the treatment of nausea and vomiting caused by cytostatic drugs (author's transl) clinical studies].
Higi M; Niederle N; Bremer K; Schmitt G; Schmidt CG; Seeber S
Dtsch Med Wochenschr; 1982 Aug; 107(33):1232-4. PubMed ID: 7049655
[No Abstract] [Full Text] [Related]
30. Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
Joss RA; Galeazzi RL; Bischoff A; Do DD; Goldhirsch A; Brunner KW
Cancer Chemother Pharmacol; 1982; 9(1):61-4. PubMed ID: 7139853
[TBL] [Abstract][Full Text] [Related]
31. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
Bruera ED; Roca E; Cedaro L; Chacón R; Estévez R
Cancer Treat Rep; 1983 Apr; 67(4):381-3. PubMed ID: 6342770
[TBL] [Abstract][Full Text] [Related]
32. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
Perez EA
Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
[TBL] [Abstract][Full Text] [Related]
33. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
34. A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
Hutcheon AW; Palmer JB; Soukop M; Cunningham D; McArdle C; Welsh J; Stuart F; Sangster G; Kaye S; Charlton D
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1087-90. PubMed ID: 6352278
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
Osorio-Sanchez JA; Karapetis C; Koczwara B
Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
[TBL] [Abstract][Full Text] [Related]
36. Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations.
Diasio RB; Ettinger DS; Satterwhite BE
J Clin Pharmacol; 1981; 21(S1):81S-85S. PubMed ID: 7298876
[TBL] [Abstract][Full Text] [Related]
37. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
38. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
Lucas VS; Laszlo J
JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
[TBL] [Abstract][Full Text] [Related]
39. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
40. delta 9-tetrahydrocannabinol in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
